According to Armata Pharmaceuticals's latest financial reports the company has $13.52 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $14.85 M | 44.36% |
2021-12-31 | $10.28 M | 6.62% |
2020-12-31 | $9.64 M | 59.94% |
2019-12-31 | $6.03 M | -26.04% |
2018-12-31 | $8.15 M | 58.94% |
2017-12-31 | $5.13 M | -10.14% |
2016-12-31 | $5.71 M | -39.05% |
2015-12-31 | $9.37 M | 42.38% |
2014-12-31 | $6.58 M | -67.67% |
2013-12-31 | $20.35 M | 2261.37% |
2012-12-31 | $0.86 M | |
2008-12-31 | $5.21 M | -68.28% |
2007-12-31 | $16.44 M | 164.94% |
2006-12-31 | $6.2 M | -56.05% |
2005-12-31 | $14.12 M | -58.58% |
2004-12-31 | $34.09 M | 61.92% |
2003-12-31 | $21.05 M | 67.04% |
2002-12-31 | $12.6 M | -49.95% |
2001-12-31 | $25.18 M |